We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) (MATICCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01344122
Recruitment Status : Completed
First Posted : April 28, 2011
Last Update Posted : October 30, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:
The goal of this study is to see whether or not a strategic planning process is able to introduce and sustain improvements in the working relationship between probation/parole departments and community-based addiction treatment agencies that provide medication assisted therapy (MAT) for individuals with opioid or alcohol dependence. In addition, this study seeks to improve probation/parole agency personnel's knowledge and perceptions about MAT, and increase the number of appropriate referrals to community treatment agencies that provide MAT. There are three phases to this study. Phase 1 includes a pilot study to determine the quality and availability of client level records and the collection of baseline data (the pilot study protocol was previously submitted to TMH IRB). Phase 2 will consist of a Knowledge, Perceptions and Information (KPI) intervention during which probation/parole agencies will undergo training to increase knowledge about the effectiveness of MAT, and complete a post training assessment to evaluate the effectiveness of the KPI intervention. During Phase 3, probation/parole agencies will be randomly assigned to a 12-month Organizational Linkage Intervention (OLI) condition or to control (no further intervention). Agencies assigned to the OLI will establish a Pharmacotherapy Exchange Council (PEC) that consists of staff from both the probation/parole and community treatment agencies. The PEC will undergo a strategic planning process to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole.

Condition or disease Intervention/treatment
Opioid-Related Disorders Alcohol-Related Disorders Other: KPI training only Other: KPI plus OLI

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)
Study Start Date : October 2010
Primary Completion Date : September 2013
Study Completion Date : September 2013
Arms and Interventions

Arm Intervention/treatment
Active Comparator: KPI training only
Study sites randomized to this arm will receive a knowledge, perceptions and information (KPI) training for community correctional and treatment staff to address knowledge, perceptions, and information regarding local resources about MAT.
Other: KPI training only
See comparison arm description.
Experimental: KPI plus OLI
Study sites randomized to this arm will receive the KPI training plus a Organizational Linkage Intervention (OLI) that will: (a) establish a local Pharmacotherapy Exchange Council (PEC) among agencies important for the implementation of MAT in community corrections; (b) facilitate a strategic planning process within the PEC to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole; and (c) identify a community corrections coordinator in one of the local agencies to operationalize and implement the strategic plan.
Other: KPI plus OLI
See experimental arm description.

Outcome Measures

Primary Outcome Measures :
  1. Opinions About MAT [ Time Frame: 6-month follow-up ]
    Measures knowledge, perceptions, and intentions regarding the use of pharmacotherapy for the treatment of opioid and alcohol dependence. Will be assessed at baseline, post-training, post intervention, and 6-month follow-up.

Secondary Outcome Measures :
  1. Interorganizational Relationships [ Time Frame: 6-month follow-up ]
    Will be assessed at baseline, and post intervention (6-month follow-up).

  2. Referrals to Medication Assisted Treatment (MAT) [ Time Frame: 6-Month Follow-up ]
    Estimated numbers of alcohol- and opiate-dependent offenders on Probation/Parole

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Probation/parole or community treatment agency staff.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01344122

Sponsors and Collaborators
Rhode Island Hospital
Arizona State University
Friends Research Institute, Inc.
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)
Temple University
Texas Christian University
University of California, Los Angeles
University of Connecticut
University of Delaware
University of Kentucky
University of Puerto Rico
Principal Investigator: Peter D Friedmann, MD, MPH Rhode Island Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Peter D. Friedmann, Professor, Rhode Island Hospital
ClinicalTrials.gov Identifier: NCT01344122     History of Changes
Other Study ID Numbers: CJDATS2-001
U01DA016191 ( U.S. NIH Grant/Contract )
First Posted: April 28, 2011    Key Record Dates
Last Update Posted: October 30, 2014
Last Verified: October 2014

Additional relevant MeSH terms:
Opioid-Related Disorders
Alcohol-Related Disorders
Pathologic Processes
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders